197 related articles for article (PubMed ID: 22974822)
41. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
42. [Influence of moxibustion with different duration on colonic epithelial structure, serum inflammatory cytokines, and intestinal mucosa inflammatory cell signal transduction pathways].
Ma TM; Han Y; Ma XD; Zeng XX; Ge W
Zhen Ci Yan Jiu; 2014 Feb; 39(1):20-6. PubMed ID: 24684107
[TBL] [Abstract][Full Text] [Related]
43. [Activation of nuclear factor-kappaB and its relationship with cytokine gene expression in colonic mucosa of ulcerative colitis patients].
Gan H; Ouyang Q; Jia D; Xia Q
Zhonghua Nei Ke Za Zhi; 2002 Apr; 41(4):252-5. PubMed ID: 12133438
[TBL] [Abstract][Full Text] [Related]
44. A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease.
Vossenkämper A; Hundsrucker C; Page K; van Maurik A; Sanders TJ; Stagg AJ; Das L; MacDonald TT
Gastroenterology; 2014 Jul; 147(1):172-83. PubMed ID: 24704524
[TBL] [Abstract][Full Text] [Related]
45. Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings.
Yamamoto T; Saniabadi AR; Umegae S; Matsumoto K
Inflamm Bowel Dis; 2006 Aug; 12(8):719-26. PubMed ID: 16917227
[TBL] [Abstract][Full Text] [Related]
46. Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcγR-mediated CD14 macrophage activation.
Uo M; Hisamatsu T; Miyoshi J; Kaito D; Yoneno K; Kitazume MT; Mori M; Sugita A; Koganei K; Matsuoka K; Kanai T; Hibi T
Gut; 2013 Dec; 62(12):1734-44. PubMed ID: 23013725
[TBL] [Abstract][Full Text] [Related]
47. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
49. Endoscopic finding of spontaneous hemorrhage correlates with tumor necrosis factor alpha expression in colonic mucosa of patients with ulcerative colitis.
Hozumi H; Hokari R; Kurihara C; Narimatsu K; Sato H; Sato S; Ueda T; Higashiyama M; Okada Y; Watanabe C; Komoto S; Tomita K; Kawaguchi A; Nagao S; Miura S
Int J Colorectal Dis; 2013 Aug; 28(8):1049-55. PubMed ID: 23377880
[TBL] [Abstract][Full Text] [Related]
50. Greatly increased mucosal nitric oxide in ulcerative colitis determined in situ by a novel nitric oxide-selective microelectrode.
Iwashita E
J Gastroenterol Hepatol; 1998 Apr; 13(4):391-5. PubMed ID: 9641303
[TBL] [Abstract][Full Text] [Related]
51. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.
Zezos P; Patsiaoura K; Nakos A; Mpoumponaris A; Vassiliadis T; Giouleme O; Pitiakoudis M; Kouklakis G; Evgenidis N
Colorectal Dis; 2014 Dec; 16(12):O420-30. PubMed ID: 25040651
[TBL] [Abstract][Full Text] [Related]
52. Functional interactions between mucosal IL-1, IL-ra and TGF-beta 1 in ulcerative colitis.
Ashwood P; Harvey R; Verjee T; Wolstencroft R; Thompson RP; Powell JJ
Inflamm Res; 2004 Feb; 53(2):53-9. PubMed ID: 15021969
[TBL] [Abstract][Full Text] [Related]
53. [IL-6 and TNF-α gene expression in the rectal mucosal of patients with chronic idiopathic ulcerative colitis and controls].
Fonseca-Camarillo GC; Villeda-Ramírez MA; Sánchez-Muñoz F; Barreto-Zúñiga R; Domínguez-López A; Uribe-Esquivel M; Yamamoto-Furusho JK
Rev Gastroenterol Mex; 2009; 74(4):334-40. PubMed ID: 20423763
[TBL] [Abstract][Full Text] [Related]
54. A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naïve and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression.
Diab J; Al-Mahdi R; Gouveia-Figueira S; Hansen T; Jensen E; Goll R; Moritz T; Florholmen J; Forsdahl G
Inflamm Bowel Dis; 2019 Feb; 25(3):490-497. PubMed ID: 30476077
[TBL] [Abstract][Full Text] [Related]
55. Influence of receptor activator of nuclear factor kappa B ligand, osteoprotegerin and interleukin-33 on bone metabolism in patients with long-standing ulcerative colitis.
Stanisławowski M; Wiśniewski P; Guzek M; Wierzbicki PM; Adrych K; Smoczyński M; Sworczak K; Celiński K; Kmieć Z
J Crohns Colitis; 2014 Aug; 8(8):802-10. PubMed ID: 24439762
[TBL] [Abstract][Full Text] [Related]
56. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon.
Keshavarzian A; Fusunyan RD; Jacyno M; Winship D; MacDermott RP; Sanderson IR
Am J Gastroenterol; 1999 Mar; 94(3):704-12. PubMed ID: 10086655
[TBL] [Abstract][Full Text] [Related]
57. The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients.
Lobatón T; Bessissow T; De Hertogh G; Lemmens B; Maedler C; Van Assche G; Vermeire S; Bisschops R; Rutgeerts P; Bitton A; Afif W; Marcus V; Ferrante M
J Crohns Colitis; 2015 Oct; 9(10):846-52. PubMed ID: 26116558
[TBL] [Abstract][Full Text] [Related]
58. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease.
Vainer B; Nielsen OH; Hendel J; Horn T; Kirman I
Cytokine; 2000 Oct; 12(10):1531-6. PubMed ID: 11023669
[TBL] [Abstract][Full Text] [Related]
59. Mucosal inflammation in the terminal ileum of ulcerative colitis patients: endoscopic findings and cytokine profiles.
Yamamoto T; Maruyama Y; Umegae S; Matsumoto K; Saniabadi AR
Dig Liver Dis; 2008 Apr; 40(4):253-9. PubMed ID: 18243079
[TBL] [Abstract][Full Text] [Related]
60. Characterization of Growth Hormone Resistance in Experimental and Ulcerative Colitis.
Soendergaard C; Kvist PH; Thygesen P; Reslow M; Nielsen OH; Kopchick JJ; Holm TL
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28946616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
